thymidine 5'-triphosphate has been researched along with lamivudine triphosphate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, NA; Brooks, JL; Bruice, TW; Chen, F; Cook, PD; Ewing, GJ; Fagan, P; Hurd, T; Leeds, JM; Prhavc, M; Rajwanshi, VK; Wang, G | 1 |
| Mellors, JW; Radzio, J; Sheen, CW; Sluis-Cremer, N; Zelina, S | 1 |
| Amblard, F; Bassit, L; Bondada, L; Coats, SJ; Detorio, M; Grier, J; Hernandez-Santiago, BI; Koontz, D; Mellors, JW; Rapp, KL; Schinazi, RF; Sluis-Cremer, N | 1 |
3 other study(ies) available for thymidine 5'-triphosphate and lamivudine triphosphate
| Article | Year |
|---|---|
Synthesis of 2',3'-dideoxynucleoside 5'-alpha-P-borano-beta,gamma-(difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcriptase.
Topics: Animals; Anti-HIV Agents; Boron Compounds; Cattle; Deoxyribonucleotides; HIV Reverse Transcriptase; In Vitro Techniques; Reverse Transcriptase Inhibitors; Stereoisomerism | 2005 |
Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 Reverse transcriptase facilitates dual resistance to zidovudine and lamivudine.
Topics: Anti-HIV Agents; Drug Resistance, Multiple, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lamivudine; Models, Molecular; Mutation; Reverse Transcriptase Inhibitors; Thermodynamics; Zidovudine | 2008 |
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Molecular Structure; Reverse Transcriptase Inhibitors | 2009 |